1. Home
  2. EEIQ vs PULM Comparison

EEIQ vs PULM Comparison

Compare EEIQ & PULM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo EpicQuest Education Group International Limited

EEIQ

EpicQuest Education Group International Limited

HOLD

Current Price

$3.55

Market Cap

5.1M

Sector

Real Estate

ML Signal

HOLD

Logo Pulmatrix Inc.

PULM

Pulmatrix Inc.

N/A

Current Price

$1.38

Market Cap

5.3M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
EEIQ
PULM
Founded
2017
2003
Country
United States
United States
Employees
N/A
2
Industry
Other Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.1M
5.3M
IPO Year
2019
2013

Fundamental Metrics

Financial Performance
Metric
EEIQ
PULM
Price
$3.55
$1.38
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
9.7K
27.2K
Earning Date
01-28-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
46.18
EPS
N/A
N/A
Revenue
N/A
$7,910,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
5069.93
52 Week Low
$0.15
$1.16
52 Week High
$12.70
$5.50

Technical Indicators

Market Signals
Indicator
EEIQ
PULM
Relative Strength Index (RSI) 68.00 43.68
Support Level $3.59 $1.21
Resistance Level $3.82 $1.44
Average True Range (ATR) 0.20 0.08
MACD 0.06 0.00
Stochastic Oscillator 79.79 23.33

Price Performance

Historical Comparison
EEIQ
PULM

About EEIQ EpicQuest Education Group International Limited

EpicQuest Education Group International Ltd provides comprehensive education solutions for domestic and international students interested in university and college degree programs in the U.S, Canada, and the UK. In addition, the company has a recruiting relationship with the regional campuses of Miami University of Ohio, where it maintains residential facilities, a full-service cafeteria, recreational facilities, shuttle buses, and an office for the regional campuses that provides study abroad and post-study services for its students; these facilities are not owned, maintained, operated or are part of Miami University. The Company's revenue is derived from foreign education programs, university education programs and student accommodation services.

About PULM Pulmatrix Inc.

Pulmatrix Inc is a biopharmaceutical company focused on the development of novel inhaled therapeutic products intended to prevent and treat migraine and respiratory diseases with important unmet medical needs using its patented dry powder delivery technology, iSPERSE. Its pipeline of clinical assets includes PUR3100 for the treatment of acute migraine, PUR1800 for the treatment of acute exacerbations of chronic obstructive pulmonary disease (AECOPD), and PUR1900 for the treatment of ABPA in patients with asthma and in patients with cystic fibrosis (CF).

Share on Social Networks: